Long-term pain requires a holistic approach that includes nonpharmacologic measures along with opioids.
No consistent observations between metabolic syndrome and walking speed, self-reported disability.
Mean percentage of increase in the HDL and LDL cholesterol levels was higher among patients receiving tofacitinib 5 mg twice daily and those receiving tofacitinib 10 mg twice daily.
Patients with rheumatoid arthritis had higher levels of insulin resistance, but they were not associated with atherosclerosis.
Developing drugs that selectively block specific sodium channels could be the holy grail of neuropathic pain treatment.
Spinal cord stimulation successfully treated painful diabetic peripheral neuropathy in 59% of patients.
Patients with diabetic peripheral neuropathy may be at an increased risk for falling while climbing or descending stairs.